blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4255576

EP4255576 - METHODS TO SENSITIZE CANCER CELLS TO IMMUNE ATTACK USING ATRACTYLENOLIDE I [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.09.2023
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  17.06.2022
Most recent event   Tooltip09.02.2024Change: Validation statespublished on 13.03.2024  [2024/11]
09.02.2024Change - extension statespublished on 13.03.2024  [2024/11]
Applicant(s)For all designated states
The Trustees of Indiana University
107 S. Indiana Avenue
Bloomington, IN 47405 / US
[2023/41]
Inventor(s)01 / LU, Xiongbin
Carmel, Indiana 46032 / US
02 / ZHANG, Xinna
Carmel, Indiana 46032 / US
03 / VAN DER JEUGHT, Kevin
Indianapolis, Indiana 46202 / US
 [2023/41]
Representative(s)V.O.
P.O. Box 87930
2508 DH Den Haag / NL
[2023/41]
Application number, filing date21904128.230.11.2021
[2023/41]
WO2021US61295
Priority number, dateUS202063122232P07.12.2020         Original published format: US 202063122232 P
[2023/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2022125339
Date:16.06.2022
Language:EN
[2022/24]
Type: A2 Application without search report 
No.:EP4255576
Date:11.10.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 16.06.2022 takes the place of the publication of the European patent application.
[2023/41]
Search report(s)International search report - published on:US25.08.2022
ClassificationIPC:A61P35/00, A61K39/00, A61K35/17
[2023/41]
CPC:
A61K45/06 (EP,US); A61K31/365 (EP,US); A61K39/39 (EP);
A61K39/39558 (EP); A61K39/4611 (EP,US); A61K39/4632 (EP,US);
A61K39/4644 (EP,US); A61P35/00 (EP,US); C07K16/2818 (EP);
C12N5/0638 (EP,US); C12N2501/999 (EP) (-)
C-Set:
A61K31/365, A61K2300/00 (EP);
A61K39/39558, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/41]
TitleGerman:VERFAHREN ZUR SENSIBILISIERUNG VON KREBSZELLEN GEGENÜBER EINEM IMMUNANGRIFF UNTER VERWENDUNG VON ATRACTYLENOLID I[2023/41]
English:METHODS TO SENSITIZE CANCER CELLS TO IMMUNE ATTACK USING ATRACTYLENOLIDE I[2023/41]
French:MÉTHODES POUR SENSIBILISER DES CELLULES CANCÉREUSES À UNE ATTAQUE IMMUNITAIRE À L'AIDE D'ATRACTYLÉNOLIDE I[2023/41]
Entry into regional phase29.06.2023National basic fee paid 
29.06.2023Search fee paid 
29.06.2023Designation fee(s) paid 
29.06.2023Examination fee paid 
Examination procedure29.06.2023Amendment by applicant (claims and/or description)
29.06.2023Examination requested  [2023/41]
Fees paidRenewal fee
27.11.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9734472  (UNIV YALE [US], et al);
 [A]US2017202937  (WEINSCHENK TONI [DE], et al);
 [XYA]CN108478557  (UNIV ZHEJIANG CHINESE MEDICAL);
 [Y]US2019321370  (SORRENTINO JESSICA A [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.